Tumor-derived VEGF-A can inhibit the activation of the transcription factor nuclear factor-κB (NF-κB) via VEGFR-1 signaling and thereby prevents dendritic cells (DC) maturation [12, 13, 16]. This evidence concerns the gene FLT1 and neoplasm.